Didier Raoult

USPTO Granted Patents = 19 (Patent Applications = 11)

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 23 (Patent Applications = 37)

Average Co-Inventor Count = 2.8

ph-index = 2

Forward Citations = 32(Granted Patents)

Location History:

Marseille, FR (2006 - 2007)
Marseilles, FR (1999 - 2021)

Company Filing History:

10 out of 230

Université´ D'aix-marseille

patents

9 out of 5,089

Centre National De La Recherche Scientifique

Fondation Mediterranee Infection

patents

5. 3 out of 14

Assistance Publique Hopitaux De Marseille

patents

6. 3 out of 1,744

Institut National De La Sante Et De La Recherche Medicale

patents

7. 2 out of 2

Fondation Mediterranee Infection Faculté De Médecine

patents

8. 2 out of 2

Protisvalor Mediterranee

patents

9. 1 out of 67

Centre National De La Recherche Scientifique-cnrs

patents

10. 1 out of 38

Inserm (institut National De La Sante Et De La Recherche Medicale)

patents

11. 1 out of 1

Universite De La Mediterranee (aix-marsille Ii)

patent

12. 1 out of 222

Galderma Research & Development

patents

13. 1 out of 10

Université De La Méditerranée - Aix-marseille II

patents

14. 1 out of 8

Université De La Méditerranée

patents

where one patent can have more than one assignee

Years Active: 1999-2021

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11091735 - Polyvalent culture medium for anaerobic bacteria under aerobic conditions (2021-08-17),

2. 10837044 - Automated method for analyzing and interpreting an antimicrobial susceptibility (2020-11-17),

3. 10626421 - Use of uric acid for culturing bacteria sensitive to oxygen tension (2020-04-21),

4. 10202587 - Vulcanisaetal phosphotriesterase-like lactonases (PLL) having enhanced properties and the uses thereof (2019-02-12),

5. 10125400 - Method for the diagnosis of rosacea (2018-11-13),

6. 10072252 - Sulfolobal phosphotriesterase-like (PLL) lactonases activity having enhanced properties and the uses thereof (2018-09-11),

7. 10011852 - Method for producing methane by means of aerobic co-culture of anaerobic micro-organisms (2018-07-03),

8. 9700051 - Use of squalamine or analogue as a disinfecting agent (2017-07-11),

9. 9493769 - Yeast-based assay for measuring the functional activity of an HIV-1 protease in response to an antiviral agent (2016-11-15),

10. 8841087 - Mycobacteria culture medium and method including mycobacteria of mycobacterium tuberculosis complex (2014-09-23),

11. 8440808 - [object Object] (2013-05-14),

12. 8378078 - Diagnosis of Whipple's disease (2013-02-19),

13. 7989161 - Methods for determining human immunodeficiency virus type 2 (HIV-2) protease sensitivity or resistance to antivirals utilizing an inducible yeast expression system (2011-08-02),

14. 7883870 - [object Object] (2011-02-08),

15. 7601822 - [object Object] (2009-10-13),

Title: The Innovative Journey of Inventor Didier Raoult

Introduction: Didier Raoult, a renowned male inventor hailing from Marseilles, France, has made significant contributions to the field of science and innovation.

Latest Patents: Didier Raoult holds several patents in the medical and biotechnology sectors, focusing on novel diagnostic tools and treatment methods for infectious diseases.

Career Highlights: With a distinguished career in microbiology and infectious diseases, Raoult is known for his groundbreaking research in areas such as emerging viruses, antibiotic resistance, and innovative therapeutic approaches.

Collaborations: Throughout his career, Didier Raoult has collaborated with leading scientists, research institutions, and pharmaceutical companies worldwide to advance the frontiers of medical innovation and improve global healthcare outcomes.

Conclusion: In conclusion, Didier Raoult's pioneering work as an inventor and researcher continues to have a profound impact on the field of microbiology, shaping the future of healthcare and inspiring the next generation of innovators.

This text is generated by artificial intelligence and may not be accurate.